English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Patient Daily | Dec 8, 2025

Epcoritamab combined with standard therapy improves survival in relapsed follicular lymphoma

Patient Daily | Dec 8, 2025

Chemotherapy-only regimen shows similar success as irradiation before B-ALL transplant

Patient Daily | Dec 8, 2025

Yale New Haven Health urges caution over toy safety during holiday shopping

Patient Daily | Dec 8, 2025

Virtual diet and exercise program may help lymphoma patients manage treatment side effects

Patient Daily | Dec 8, 2025

Air travel tips help passengers with hearing loss navigate airports and flights

Patient Daily | Dec 8, 2025

GSK ends cancer research partnership with Ideaya Biosciences after five years

Patient Daily | Dec 8, 2025

ASH meeting highlights new CAR-T advances and updates on sickle cell disease treatments

Patient Daily | Dec 8, 2025

Tulane study finds ablation reduces risks for patients with AFib and sleep apnea

Trending

+ Regulatory
A. D. Alderman | Jun 11, 2026

Pharmacist Crisp on PBM reform bills: 'Middleman that owns the pharmacy, sets the price, pays itself, and audits its own books'

+ Regulatory
A. D. Ahrens | Jun 11, 2026

Economist: 'The 340B program has been hijacked by tax-exempt hospitals'

+ Regulatory
Patient Daily | Jun 16, 2026

PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'

+ Regulatory
Patient Daily | Jun 12, 2026

Taxpayer advocate: 340B drug discount program offers 'perverse incentives'

  • « First
  • «
  • …
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily